Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections

BACKGROUND: Although the prognostic value of Ki67 in breast cancer is well documented, using optimal cut-points for patient stratification, reproducibility of the scoring and interpretation of the results remains a matter of debate particularly when using tissue microarrays (TMAs). This study aims t...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Breast Cancer Res Treat
Auteurs principaux: Muftah, Abir A., Aleskandarany, Mohammed A., Al-kaabi, Methaq M., Sonbul, Sultan N., Diez-Rodriguez, Maria, Nolan, Chris C., Caldas, Carlos, Ellis, Ian O., Rakha, Emad A., Green, Andrew R.
Format: Artigo
Langue:Inglês
Publié: Springer US 2017
Sujets:
Preclinical Study
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5487701/
https://ncbi.nlm.nih.gov/pubmed/28478613
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-017-4270-0
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires